Search filters

List of works by Megan Wind-Rotolo

A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection ⬇️

scientific article published on May 22, 2013

A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients

scientific article

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

scientific article published on 2 January 2015

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.

scientific article published on 19 August 2016

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

scientific article published on 18 June 2012

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

scientific article published on 30 July 2014

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

scientific article published on 30 October 2013

Experimental approaches to the study of HIV-1 latency

scientific article published on February 2007

Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.

scientific article published on May 2009

In VitroAntiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068 ⬇️

scientific article published on April 30, 2012

Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site

scientific article

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs

scientific article published in August 2004

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

scientific article

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).

scientific article

Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects ⬇️

scientific article published on August 14, 2012

Prediction of Virological Response and Assessment of Resistance Emergence to the HIV-1 Attachment Inhibitor BMS-626529 During 8-Day Monotherapy With Its Prodrug BMS-663068 ⬇️

scientific article published on September 1, 2013

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 ⬇️

scientific article published on January 19, 2012

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

scientific article published on 26 October 2013

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

scientific article

The HBV drug entecavir - effects on HIV-1 replication and resistance

scientific article

Viral latency and reservoirs: relevance for mother-to-child transmission and resistance

scientific article published on March 2006

Paulina is supported by:

About Paulina

Help